Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
EHVVF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Google Partner NovaCore Labs and AIBotics Advance Acquisition and Expand Robot Deployment Across Jamaica
KEENON Robotics, a Global Leader in Service Robotics, Partners With AIBotics and NovaCore Labs to Enter Jamaican Market Accelerate Into High-Demand Caribbean Markets MIAMI and KINGSTON, Jamaica, April 30, 2026 (GLOBE NEWSWIRE) -- AIBotics,…
KEENON Robotics Sends First Shipment of Robots to Israel Post-War Under Agreement with AIBotics and Ignites Middle East Robotics Rollout
MIAMI, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aibotics, Inc. (OTC: AIBT) (“AIBotics” or the “Company”), a developer and integrator of AI- and robotics-enhanced technologies and a subsidiary of Ehave, Inc. (OTC: EHVVF), today announced that KEEN…
KEENON Robotics, Creator of XMAN and One of the World’s Global Leaders and Largest Robotic Manufacturers, Signs Partnership Agreement With Aibotics
MIAMI, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aibotics, Inc. (OTC: AIBT)(“AIBotics” or the “Company”), a developer and manager of AI- and robotics-enhanced technologies and a subsidiary of Ehave, Inc. (OTC: EHVVF), today announced it is accele…
* Ehave (OTC:EHVVF [https://seekingalpha.com/symbol/EHVVF]) Tuesday announced the acquisition of AIHeadHunter, an artificial intelligence-powered recruitment platform, through an asset purchase agreement. * The transaction marks a signific…
Ehave Provides Progress Update on its HPPD Study with University of Melbourne
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to announce it has completed the first phase of…
FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder
MIAMI, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, announced today that it received confirmation from the U.…
Ehave Shareholder from CEO Ben Kaplan and Corporate Update
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Exec…
Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept delivery of its KetaDASH Mobile Unit in Miami…
Ehave, Inc. Announces Psychedelics Precision Medicine Platform For Clinical Research
AI-driven discovery platform enables new way to find novel pathways, as well as progress towards identifying patients who may better respond to drugs in the clinic Genetic test kit evaluates an individual's overall sensitivity and risk pro…
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ
MIAMI, May 23, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its Mycotopia Therapies (OTC: TPIA) subsidiary has signed a definitive agree…
Ehave Announces MetaHealthU Will Enter The Market With A Focus On HPPD
MIAMI, April 19, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its MetaHealthU mobile application platform will focus on determining the cause…
Ehave Continues Expansion Of KetaDASH Mobile Psychedelic Service By Providing Licensed Psychotherapists And Registered Nurses
Agreement with Heally adds doctors, licensed psychotherapists and registered nurses to the KetaDASH platform With the opening of KetaDASH, Ehave builds momentum for the psychedelic renaissance in the mental health fieldBoth the KetaDASH pa…
Ehave, Inc. Licensing Partner Vastmindz Seen By Millions Of Viewers On Unicorn Hunter
Ehave has licensed AI technology from Vastmindz for MetaHealthU.in 2022, Ehave plans to monetize the AI technology it licensed from Vastmindz to expand the Ehave Dashboard in the MetaHealthU offering to identify an individual's physiologic…
Ehave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market
KetaDASH will provide ketamine therapy for the treatment of mental health disordersKetaDASH is a managed service organization focused on the psychedelic sector with the mission of helping physicians streamline their practice operations, cr…
Ehave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IV
MIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its KetaDASH brand by completing the purchase…
Ehave Issues Shareholder Letter and Provides Corporate Update
MIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Offic…
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30% MIAMI, Dec. 08, 2021 (GLOBE NEWSW…
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly owned KetaDASH will be one of the sponsor…
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research or…
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Psychedelic Stock Review has i…
FMW Media, Inc.’s New to The Street TV Announces its 5 TV Interviews Being Broadcasted On Fox Business Network, Tonight, Monday, August 2, 2021 @ 10:30 PM PT and Tomorrow, Tuesday, August 3, 2021 @ 10:30 PM PT
FMW Media, Inc.’s New to The Street TV Announces its 5 TV Interviews Being Broadcasted On Fox Business Network, Tonight, Monday, August 2, 2021 @ 10:30 PM PT and Tomorrow, Tuesday, August 3, 2021 @ 10:30 PM PT MONDAY NIGHT's SHOW LINE-UP:…
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”
Jim Cramer discussed psychedelics on his June 15, 2021 program and said big drug companies tried, and failed, to treat major depression. Here are four psychedelic companies you need to know about that are addressing the mental health crisi…
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”
Jim Cramer discussed psychedelics on his June 15, 2021 program and said big drug companies tried, and failed, to treat major depression. Here are four psychedelic companies you need to know about that are addressing the mental health crisi…
Ehave, Inc. Announces Engagement of Legal Counsel to Advise on Launch of KetaDASH in Miami Metro Area and across United States; Ehave Creates Path to Revenue Stream
MIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company is ahead of schedule and plans launch it…
Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology
MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to launch brain mapping ketamine clinical tria…
Psilocybin Data Study Agreement Reached Between Ehave Inc. and Silo Wellness Using Brain Scientific Mapping Neurocap
MIAMI, March 23, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors, and Silo Wellness Inc. (CSE: SILO) (“Silo Wellness”), a wellness company in the psyc…
Ehave Inc. Files for KetaDash Trademark and to Uplist its Shares to the OTCQB
MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has filed application #90549575 on February 26, 2…
Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021
MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced plans to launch open testing of its KetaDASH ketamine IV th…
Psychedelic Stocks Poised to Resume the Upward Trend
Fears of inflation and higher interest rates roiled the market for growth stocks, but the long-term prospects for psychedelic medicine remains bullish ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Fears of inflation and higher interest rates…
Psychedelic Stocks Poised to Resume the Upward Trend
Fears of inflation and higher interest rates roiled the market for growth stocks, but the long-term prospects for psychedelic medicine remains bullish ATLANTA, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Fears of inflation and higher interest rates…
Psychedelic Partnership Reached, Ehave Inc. and Brain Scientific Sign Memorandum of Understanding to Map Brain Response to Psychedelic Treatment, Collaborate in the Development of Neural Net Algorithms for the Psychedelic Mental Health Sector, E-Tattoo Technology is Expected to Provide Continuous Monitoring
Ehave, Inc. to leverage data and AI to correlate biomarkers for the identification of psychedelic drug administration as a treatment for Chronic pain, Depression (major and persistent), PTSD, Bipolar disorder, General anxiety, ADHD and Sch…
264 Million Reasons Psychedelic Stocks Have More Room to Grow
There is big money to be made from psychedelic stocks and the companies planning to treat depression will be the winners. ATLANTA, Feb. 11, 2021 (GLOBE NEWSWIRE) -- OTC Stock Review: Unless you have been hiding under a rock for the last ye…
Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression
MIAMI, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, is announcing plans to roll out its ketamine home delivery platform k…
MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it is exploring how palliative patients could benefit…
4 Top Stocks for Huge Gains from the Psychedelic Renaissance
Psychedelic drugs as treatment are paving the way for major gains in psychedelic stocks ATLANTA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- OTC Stock Review was early to the party with an article on Seeking Alpha March 6, 2020 titled "Psychedelic M…
Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare
MIAMI, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to continue to address the needs of big data ma…